ID
24504
Description
NCT00079911 Study ID 100181 Clinical Study ID HS2100181 Study Title: An International, Randomized, Double-Blind, Placebo-Controlled Study of Valaciclovir for the Suppression and Episodic Treatment of Genital HSV Infection in HIV-Infected Persons with CD4+ lymphocyte count <100 cells/mm3. Patient Level Data Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00079911 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 4 Study Recruitment Status: Terminated Generic Name: valaciclovir Trade Name: ZELITREX,Valtrex,RAPIVIR,Novirus Study Indication: Genital Herpes; HIV infection
Mots-clés
Versions (1)
- 03/08/2017 03/08/2017 -
Détendeur de droits
GlaxoSmithKline
Téléchargé le
3 août 2017
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY-NC 3.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
GSK Valaciclovir for the Suppression and Episodic Treatment of Genital HSV Infection in HIV-Infected Persons GENITAL HERPES RECURRENCES NCT00079911
GSK Valaciclovir for the Suppression and Episodic Treatment of Genital HSV Infection in HIV-Infected Persons GENITAL HERPES RECURRENCES NCT00079911
Description
GENITAL HERPES RECURRENCES
Description
Date of Onset of Recurrence
Type de données
date
Alias
- UMLS CUI [1]
- C0807712
Description
recurrence confirmed
Type de données
text
Alias
- UMLS CUI [1,1]
- C1274323
- UMLS CUI [1,2]
- C0521093
- UMLS CUI [1,3]
- C0031809
Description
Date of Exam
Type de données
date
Alias
- UMLS CUI [1]
- C2826643
Description
Date Home Culture Collected
Type de données
date
Alias
- UMLS CUI [1,1]
- C1294251
- UMLS CUI [1,2]
- C0442519
- UMLS CUI [1,3]
- C1317250
Description
Date Clinic Culture Collected
Type de données
date
Alias
- UMLS CUI [1,1]
- C1294251
- UMLS CUI [1,2]
- C0442592
- UMLS CUI [1,3]
- C1317250
Description
If Yes, record Open-Label Valaciclovir on lnvestigational Product page.
Type de données
text
Alias
- UMLS CUI [1]
- C0249458
Description
day 5 visit
Type de données
text
Alias
- UMLS CUI [1,1]
- C0545082
- UMLS CUI [1,2]
- C3842674
Description
day 5 visit date
Type de données
date
Alias
- UMLS CUI [1,1]
- C1320303
- UMLS CUI [1,2]
- C3842674
Description
If Yes, record Open-Label Valaciclovir on lnvestigational Product page.
Type de données
text
Alias
- UMLS CUI [1,1]
- C0249458
- UMLS CUI [1,2]
- C0545082
- UMLS CUI [1,3]
- C3842674
Description
day 10 visit
Type de données
text
Alias
- UMLS CUI [1,1]
- C0545082
- UMLS CUI [1,2]
- C0439228
- UMLS CUI [1,3]
- C0205456
Description
day 10 visit date
Type de données
date
Alias
- UMLS CUI [1,1]
- C1320303
- UMLS CUI [1,2]
- C0439228
- UMLS CUI [1,3]
- C0205456
Similar models
GSK Valaciclovir for the Suppression and Episodic Treatment of Genital HSV Infection in HIV-Infected Persons GENITAL HERPES RECURRENCES NCT00079911
C0521093 (UMLS CUI [1,2])
C0031809 (UMLS CUI [1,3])
C0442519 (UMLS CUI [1,2])
C1317250 (UMLS CUI [1,3])
C0442592 (UMLS CUI [1,2])
C1317250 (UMLS CUI [1,3])
C3842674 (UMLS CUI [1,2])
C0545082 (UMLS CUI [1,2])
C3842674 (UMLS CUI [1,3])
C0439228 (UMLS CUI [1,2])
C0205456 (UMLS CUI [1,3])
C0439228 (UMLS CUI [1,2])
C0205456 (UMLS CUI [1,3])